Literature DB >> 33752866

Acute Kidney Disease to Chronic Kidney Disease.

Javier A Neyra1, Lakhmir S Chawla2.   

Abstract

Acute kidney injury (AKI) and chronic kidney disease are common interconnected syndromes that represent a public health problem. Acute kidney disease (AKD) is defined as the post-AKI status of acute or subacute kidney damage/dysfunction manifested by persistence of AKI beyond 7 to 90 days after the initial AKI diagnosis. Limited clinical data exist regarding AKD epidemiology but its incidence is observed in ∼25% of AKI survivors. Useful risk-stratification tools to predict risk of AKD and its prognosis are needed. Interventions on fluid management, nephrotoxic exposure, and follow-up care hold promise to ameliorate the burden of AKD and its complications.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKD; AKI; Acute kidney disease; Acute kidney injury; CKD; Chronic kidney disease; Kidney recovery

Year:  2021        PMID: 33752866     DOI: 10.1016/j.ccc.2020.11.013

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  5 in total

1.  VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity.

Authors:  Laurence M Black; Elisa R Farrell; Daria Barwinska; Gunars Osis; Anna A Zmijewska; Amie M Traylor; Stephanie K Esman; Subhashini Bolisetty; Grace Whipple; Malgorzata M Kamocka; Seth Winfree; Daryll R Spangler; Shehnaz Khan; Abolfazl Zarjou; Tarek M El-Achkar; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-18

2.  Electrochemical N-Acetyl-β-D-glucosaminidase Urinalysis: Toward Sensor Chip-Based Diagnostics of Kidney Malfunction.

Authors:  Piyanuch Vibulcharoenkitja; Wipa Suginta; Albert Schulte
Journal:  Biomolecules       Date:  2021-09-30

Review 3.  Targeting ferroptosis in acute kidney injury.

Authors:  Lihua Ni; Cheng Yuan; Xiaoyan Wu
Journal:  Cell Death Dis       Date:  2022-02-24       Impact factor: 9.685

4.  Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes.

Authors:  Jason A Collett; Victor Ortiz-Soriano; Xilong Li; Alexander H Flannery; Robert D Toto; Orson W Moe; David P Basile; Javier A Neyra
Journal:  Crit Care       Date:  2022-04-14       Impact factor: 9.097

Review 5.  Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers.

Authors:  Stefano D'Errico; Martina Zanon; Davide Radaelli; Monica Concato; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Biomedicines       Date:  2022-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.